Quarterly ResultJul 30, 2026, 06:08 AM
Takeda Q1 Revenue +10.2% to JPY 1,219.9B; Core OP +11.5%
AI Summary
Takeda Pharmaceutical reported its first-quarter FY2026 results, with revenue increasing by 10.2% to JPY 1,219.9 billion and core operating profit rising by 11.5% to JPY 358.9 billion. However, reported net profit attributable to owners decreased by 8.9% to JPY 113.2 billion, and adjusted free cash flow saw a significant decline of 63.9% to JPY 68.6 billion. The company also provided its full-year FY2026 forecast, projecting a substantial increase in reported operating profit and net profit.
Key Highlights
- Q1 Revenue increased 10.2% to JPY 1,219.9 billion.
- Q1 Core Operating Profit rose 11.5% to JPY 358.9 billion.
- Q1 Reported Net Profit attributable to owners decreased 8.9% to JPY 113.2 billion.
- Q1 Adjusted Free Cash Flow declined 63.9% to JPY 68.6 billion.
- FY2026 full-year reported operating profit forecast at JPY 420.0 billion.
- FY2026 full-year reported net profit forecast at JPY 166.0 billion.
- FY2026 full-year Core Operating Profit forecast to decrease 1.1% to JPY 1,160.0 billion.
- Adjusted Net Debt to Adjusted EBITDA ratio was 2.7x in Q1 FY2026.
Price Impact
More from TAK